-
Feb 2, 2023, 3:05 pm124 pts
Green Market Report
Ketamine pharmaceutical company PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) has said that the U.S. Food and Drug Administration has granted orphan drug designation to its proprietary racemic ketamine drug. The drug has undergone a phase 2 clinical trial for the treatment of Rett syndrome, a rare genetic…
Trending Today on NewsBudz
NewsBudz is a marijuana and medical cannabis news app. The site delivers a daily feed of the latest cannabis news. We aggregate over 30 of the web's best sources for news about marijuana, hemp and legalization to keep you informed.
Stay on top of the latest news headlines, trends and developments worldwide around recreational and medical marijuana. Sit back and relax, while you read learn and share. On the web or your mobile device, NewsBudz is your cannabis news stream.
